{
  "type": "hyp",
  "text": "Peripheral blood mononuclear cells from seventeen patients with primary myelodysplastic syndromes (MDS) in advanced stage were enriched for blasts and tested for (1) karyotype (2) genomic configuration and (3) expression of IL-3 GM-CSF FMS and EGR-1 genes which are all located on the long arm of chromosome 5. Oct-2 mRNA levels and both c-fos and c-jun genes are not altered by treatment.\n",
  "self": {
    "NER": {
      "answers": [
        "mononuclear",
        "seventeen",
        "MDS",
        "1",
        "karyotype",
        "3",
        "IL-3 GM-CSF FMS",
        "EGR-1",
        "5",
        "mRNA"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What type of cells were enriched for blasts?",
          "How many patients were enriched for blasts?",
          "What is the term for primary myelodysplastic syndrome?",
          "How many c-jun genes are not altered by treatment?",
          "What were the cells tested for?",
          "How many genes were tested for karyotype?",
          "What is the name of the protein that is found on the long arm of chromosome",
          "What gene is found on the long arm of chromosome 5?",
          "What part of chromosome 5 are IL-3 GM-CSF FMS",
          "What is not altered by treatment?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "Peripheral blood mononuclear cells",
        "seventeen patients",
        "primary myelodysplastic syndromes",
        "MDS",
        "advanced stage",
        "blasts",
        "(1) karyotype (2) genomic configuration",
        "(3) expression",
        "IL-3 GM-CSF FMS and EGR-1 genes",
        "the long arm",
        "chromosome",
        "Oct-2 mRNA levels",
        "both c-fos and c-jun genes",
        "treatment"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What was enriched for blasts and tested for karyotype (2) genomic configuration and",
          "How many patients were enriched for blasts?",
          "What is MDS?",
          "What is the term for primary myelodysplastic syndrome?",
          "What stage of MDS are the cells from?",
          "What were the cells enriched for?",
          "What were the cells tested for?",
          "What was tested for IL-3 GM-CSF FMS and EGR-1 genes",
          "What genes were tested for expression?",
          "Where are IL-3 GM-CSF FMS and EGR-1 genes located on",
          "What part of the genome is IL-3 GM-CSF FMS located on?",
          "What was not altered by treatment?",
          "What genes are not altered by treatment?",
          "What is not altered by the blasts?"
        ]
      }
    }
  },
  "asked": {
    "What is the only factor that does not alter the level of c-jun mRNA": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.2954660654067993,
        "ground_truth": {
          "PHA": {
            "bertscore": 0.6827972531318665,
            "f1": 0
          }
        }
      }
    },
    "What protein is not altered by PHA activation?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.023609042167663574,
        "ground_truth": {
          "EC": {
            "bertscore": 0.7138954401016235,
            "f1": 0
          }
        }
      }
    },
    "What type of cells express c-jun transcripts?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.08103644847869873,
        "ground_truth": {
          "PBL": {
            "bertscore": 0.6691135764122009,
            "f1": 0
          }
        }
      }
    },
    "What do PBL constitutively express?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.038777172565460205,
        "ground_truth": {
          "c-jun transcripts": {
            "bertscore": 0.6591328382492065,
            "f1": 0
          }
        }
      }
    },
    "What is not altered by PHA activation in the absence or presence of EC?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.04334467649459839,
        "ground_truth": {
          "the level": {
            "bertscore": 0.6972552537918091,
            "f1": 0
          },
          "c-jun mRNA": {
            "bertscore": 0.6452436447143555,
            "f1": 0
          }
        }
      }
    },
    "What is not a factor that can alter the level of c-jun mRNA": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.18662768602371216,
        "ground_truth": {
          "PHA activation": {
            "bertscore": 0.6489275097846985,
            "f1": 0
          }
        }
      }
    },
    "In what condition is the level of c-jun mRNA not altered?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.09058350324630737,
        "ground_truth": {
          "the absence": {
            "bertscore": 0.6903125643730164,
            "f1": 0
          }
        }
      }
    },
    "What is the only condition that does not alter the level of c-jun mRNA": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.19721245765686035,
        "ground_truth": {
          "presence": {
            "bertscore": 0.727195143699646,
            "f1": 0
          }
        }
      }
    }
  }
}